Green kiwifruit (lat. Actinidia deliciosa var. Hayward) and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

被引:10
|
作者
Turck, Dominique
Castenmiller, Jacqueline
De Henauw, Stefaan
Hirsch-Ernst, Karen Ildico
Kearney, John
Knutsen, Helle Katrine
Maciuk, Alexandre
Mangelsdorf, Inge
McArdle, Harry J.
Naska, Androniki
Pelaez, Carmen
Pentieva, Kristina
Thies, Frank
Tsabouri, Sophia
Vinceti, Marco
Bresson, Jean-Louis
Siani, Alfonso
机构
关键词
kiwifruit; Actinidia deliciosa; defecation; health claim; DIETARY FIBER; CONSTIPATION; EXTRACT;
D O I
10.2903/j.efsa.2021.6641
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following an application from Zespri International Limited, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to green kiwifruit (lat. Actinidia deliciosa var. Hayward) and maintenance of normal defecation. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is green kiwifruit. The Panel considers that green kiwifruit (Actinidia deliciosa var. Hayward) is sufficiently characterised. The claimed effect proposed by the applicant is 'maintenance of normal defecation'. Maintenance of normal defecation is a beneficial physiological effect provided that it does not result in diarrhoea. All human intervention studies submitted had different limitations and could not be used on their own for the scientific substantiation of the claim. However, the results of six pertinent human intervention studies are consistent with respect to an effect of consuming daily between two and four green kiwifruits var. Hayward on an increase in stool frequency. Two out of four studies in which a validated instrument was used to assess stool consistency showed an effect also on stool consistency. There is evidence for a plausible mechanism by which kiwifruit could exert an effect on normal defecation. The consumption of kiwifruit in the studies did not result in diarrhoea. A cause and effect relationship has been established between the consumption of green kiwifruit (Actinidia deliciosa var. Hayward) and maintenance of normal defecation. The following wordings reflect the scientific evidence: 'consumption of kiwifruit contributes to the maintenance of normal defecation'. In order to obtain the claimed effect, two large green kiwifruits (i.e. around 200 g of kiwi flesh) should be consumed. (C) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Scientific Opinion on the modification of the authorisation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006 following a request in accordance with Article 19 of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (05)
  • [32] Scientific Opinion on the substantiation of a health claim related to caffeine and increased alertness pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (02)
  • [33] Stablor® and reduction of visceral fat while maintaining lean mass: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Turck, Dominique
    Bresson, Jean-Louis
    Burlingame, Barbara
    Dean, Tara
    Fairweather-Tait, Susan
    Heinonen, Marina
    Hirsch-Ernst, Karen Ildico
    Mangelsdorf, Inge
    McArdle, Harry J.
    Naska, Androniki
    Neuhauser-Berthold, Monika
    Nowicka, Grazyna
    Pentieva, Kristina
    Sanz, Yolanda
    Sjodin, Anders
    Stern, Martin
    Tome, Daniel
    Van Loveren, Henk
    Vinceti, Marco
    Willatts, Peter
    Martin, Ambroise
    Strain, John J.
    Siani, Alfonso
    EFSA JOURNAL, 2017, 15 (02)
  • [34] Niacin and contribution to normal energy-yielding metabolism: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2015, 13 (07)
  • [35] Vitamin C and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
    Bresson, Jean Louis
    Burlingame, Barbara
    Dean, Tara
    Fairweather-Tait, Susan
    Heinonen, Marina
    Hirsch-Ernst, Karen Ildico
    Mangelsdorf, Inge
    McArdle, Harry
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Pentieva, Kristina
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Tome, Daniel
    Turck, Dominique
    Van Loveren, Hendrik
    Vinceti, Marco
    Willatts, Peter
    EFSA JOURNAL, 2015, 13 (11)
  • [36] Vitamin D and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2015, 13 (07)
  • [37] Coffee C21 and protection of DNA from strand breaks: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Turck, Dominique
    Castenmiller, Jacqueline
    Stefaan De Henauw
    Hirsch-Ernst, Karen Ildico
    Kearney, John
    Knutsen, Helle Katrine
    Maciuk, Alexandre
    Mangelsdorf, Inge
    Mcardle, Harry J.
    Naska, Androniki
    Pelaez, Carmen
    Pentieva, Kristina
    Thies, Frank
    Tsabouri, Sophia
    Vinceti, Marco
    Bresson, Jean-Louis
    Siani, Alfonso
    EFSA JOURNAL, 2020, 18 (03)
  • [39] Scientific Opinion on the substantiation of a health claim related to Opti(EFAX)(TM) and maintenance of normal blood LDL-cholesterol concentrations pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Harmu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2012, 10 (07)
  • [40] A combination of beta-sitosterol and beta-sitosterol glucoside and normal function of the immune system: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Turck, Dominique
    Castenmiller, Jacqueline
    De Henauw, Stefaan
    Hirsch-Ernst, Karen Ildico
    Kearney, John
    Knutsen, Helle Katrine
    Maciuk, Alexandre
    Mangelsdorf, Inge
    McArdle, Harry J.
    Naska, Androniki
    Pelaez, Carmen
    Pentieva, Kristina
    Thies, Frank
    Tsabouri, Sophia
    Vinceti, Marco
    Bresson, Jean-Louis
    Siani, Alfonso
    EFSA JOURNAL, 2019, 17 (07)